• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up2.00% Nasdaq Up1.66%

    More On SUNPHARMA.NS

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials


    Sun Pharmaceutical Industries Limited (SUNPHARMA.NS)

    -NSE
    847.35 Up 16.95(2.04%) Feb 12, 5:00AM EST
    ProfileGet Profile for:
    Sun Pharmaceutical Industries Limited
    Sun House
    Plot No. 201 B/1
    Mumbai, 400063
    India - Map
    Phone: 91 22 4324 4324
    Fax: 91 22 4324 4343
    Website: http://www.sunpharma.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Biotechnology
    Full Time Employees:33,000

    Business Summary 

    Sun Pharmaceutical Industries Limited, a specialty generic pharmaceutical company, manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, such as psychiatry, anti-infectives, neurology, cardiology, orthopaedics, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynaecology, respiratory, oncology, dental, and nutritionals. It also provides APIs comprising anti-cancers, peptides, sex hormones, steroids, and controlled substances. Sun Pharmaceutical Industries Limited has a research collaboration agreement with Yeda Research & Development Company Ltd. and Fundacion Ramón Domínguez to develop products for the treatment of neurological diseases, such as brain stroke, as well as glioblastoma, a brain cancer. The company was founded in 1983 and is based in Mumbai, India.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Sun Pharmaceutical Industries Limited

    Key Executives 
     PayExercised
    Mr. Dilip Shantilal Shanghvi , 60
    Managing Director, Exec. Director, Chairman of Corp. Social Responsibility Committee, Chairman of Risk Management Committee, Member of Stakeholders’ Relationship Committee and Member of Committee of Directors
    31.53MN/A
    Mr. Uday V. Baldota ,
    Chief Financial Officer and Member of Risk Management Committee
    25.08MN/A
    Mr. Sailesh T. Desai , 62
    Sr.key Exec., Wholetime Director and Member of Committee of Directors
    10.99MN/A
    Mr. Sudhir Vrundavandas Valia , 60
    Sr.key Exec., Wholetime Director, Chairman of Committee of Directors, Member of Stakeholders’ Relationship Committee, Member of Corp. Social Responsibility Committee and Member of Risk Management Committee
    31.34MN/A
    Mr. Sunil R. Ajmera ,
    Company Sec.
    8.17MN/A
    Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in INR.